Average Co-Inventor Count = 3.46
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genetics Institute, Inc. (13 from 389 patents)
2. Hydra Biosciences, Inc. (8 from 49 patents)
3. Scpharmaceuticals Inc. (4 from 9 patents)
4. 180 Therapeutics LP (4 from 4 patents)
5. Other (1 from 832,680 patents)
6. Eli Lilly and Company (4,442 patents)
7. Boston University (818 patents)
8. Aquinnah Pharmaceuticals, Inc. (2 patents)
9. Larsen, Glenn R. (0 patent)
10. Vanderweyde, Tara (0 patent)
11. Wolozin, Benjamin (0 patent)
12. Apicco, Daniel J. (0 patent)
30 patents:
1. 12370168 - Pharmaceutical formulations for subcutaneous administration of furosemide
2. 12344667 - Method of treating early stage Dupuytren's disease
3. 11613570 - Method of treating dupuytren's disease using a pre-filled syringe
4. 11433044 - Pharmaceutical formulations for subcutaneous administration of furosemide
5. 11400154 - Method of treating a localized fibrotic disorder using an IL-33 antagonist
6. 10500273 - Method of treating a localized fibrotic disorder using an IL-33 antagonist
7. 10272064 - Pharmaceutical formulations for subcutaneous administration of furosemide
8. 9884039 - Pharmaceutical formulations for subcutaneous administration of furosemide
9. 9486455 - Compounds for modulating TRPV3 function
10. 9181219 - Compounds of modulating TRPV3 function
11. 8916550 - Compounds for modulating TRPV3 function
12. 8552009 - Substituted pyrimido 4.5-d pyrimidin-4-one compounds for modulating TRPV3 function
13. 8389546 - Compounds for modulating TRPV3 function
14. 8232252 - P-selectin ligand protein
15. 8163761 - Methods and compositions for treating disorders